Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|September 24, 2008
The cost-utility of high dose oral mesalazine for moderately active ulcerative colitisA Buckland, K BodgerBritish Medical Bulletin|May 30, 1998
Helicobacter pylori and gastric inflammationK Bodger, J E CrabtreeAlimentary Pharmacology & Therapeutics|May 15, 2009
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost dataK Bodger, T Kikuchi, D HughesJournal of Clinical Pathology|August 29, 2003
Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitopeK Bodger, F Campbell, J M RhodesGut|December 14, 2004
Predictive value of alarm features in a rapid access upper gastrointestinal cancer serviceN Kapoor, A Bassi, R Sturgess, et al.Scandinavian Journal of Gastroenterology|October 16, 1999
Serologic screening before endoscopy: the value of Helicobacter pylori serology, serum recognition of the CagA and VacA proteins, and serum pepsinogen IK Bodger, J I Wyatt, R V HeatleyGut|June 1, 1997
Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretionK Bodger, J I Wyatt, R V HeatleyAlimentary Pharmacology & Therapeutics|December 1, 1996
Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitionersK Bodger, M J Daly, R V HeatleyHelicobacter|October 31, 2001
Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopyK Bodger, J I Wyatt, R V HeatleyDigestive Diseases (Basel, Switzerland)|February 13, 2003
Dissatisfaction with consent for diagnostic gastrointestinal endoscopyA Bassi, E Brown, N Kapoor, et al.Pageof 3